Cyclic Cushing syndrome: definitions and treatment implications
- PMID: 17961029
- DOI: 10.3171/foc.2007.23.3.5
Cyclic Cushing syndrome: definitions and treatment implications
Abstract
Endogenous Cushing syndrome (CS) results from hypercortisolemia caused by excess adrenocorticotropic hormone production in a pituitary adenoma or ectopic tumor, or by an adrenal tumor that directly produces excess cortisol. The diagnosis can usually be ascertained with a reasonable degree of certainty based on clinical and laboratory findings of hypercortisolism. There are patients, however, in whom the production of excess cortisol exhibits a cyclic or intermittent pattern, and, as a result, the clinical symptoms may be quite complex and varied. In these patients the hypothalamic-pituitary-adrenal axis may be normal between cycles, and dexamethasone suppression testing may produce a paradoxical response. In the present article, the authors provide a definition of cyclic Cushing syndrome, review the causes and its potential pathophysiological mechanisms, and discuss the treatment options based on a review of the available literature.
Similar articles
-
Diagnostic approach to Cushing disease.Neurosurg Focus. 2007;23(3):E1. doi: 10.3171/foc.2007.23.3.2. Neurosurg Focus. 2007. PMID: 17961030 Review.
-
Are Cushing's disease patients curable?Ann Endocrinol (Paris). 2018 Jun;79(3):153-156. doi: 10.1016/j.ando.2018.03.012. Epub 2018 Apr 9. Ann Endocrinol (Paris). 2018. PMID: 29650226 Review.
-
Cushing's disease and pregnancy.Pituitary. 2004;7(4):237-41. doi: 10.1007/s11102-005-1479-4. Pituitary. 2004. PMID: 16132201 Review. No abstract available.
-
An approach to the evaluation and treatment of Cushing's disease.Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S37-46. doi: 10.1586/14737140.6.9s.S37. Expert Rev Anticancer Ther. 2006. PMID: 17004856 Review.
-
Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach.Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):611-26. doi: 10.1016/j.beem.2006.09.005. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 17161335 Review.
Cited by
-
Inverse problems from biomedicine: inference of putative disease mechanisms and robust therapeutic strategies.J Math Biol. 2013 Jul;67(1):143-68. doi: 10.1007/s00285-012-0523-z. Epub 2012 Apr 18. J Math Biol. 2013. PMID: 22526835
-
Bilateral inferior petrosal sinus sampling: validity, diagnostic accuracy in lateralization of pituitary microadenoma, and treatment in eleven patients with Cushing's syndrome - a single-center retrospective cohort study.BMC Endocr Disord. 2023 Oct 23;23(1):232. doi: 10.1186/s12902-023-01495-z. BMC Endocr Disord. 2023. PMID: 37872539 Free PMC article.
-
High prevalence of normal tests assessing hypercortisolism in subjects with mild and episodic Cushing's syndrome suggests that the paradigm for diagnosis and exclusion of Cushing's syndrome requires multiple testing.Horm Metab Res. 2010 Nov;42(12):874-81. doi: 10.1055/s-0030-1263128. Epub 2010 Aug 27. Horm Metab Res. 2010. PMID: 20803415 Free PMC article.
-
Testosterone and bioavailable testosterone help to distinguish between mild Cushing's syndrome and polycystic ovarian syndrome.Horm Metab Res. 2008 Nov;40(11):813-8. doi: 10.1055/s-0028-1087186. Epub 2008 Sep 25. Horm Metab Res. 2008. PMID: 18819057 Free PMC article.
-
Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review.Arch Endocrinol Metab. 2023 Nov 17;68:e220491. doi: 10.20945/2359-4292-2022-0491. Arch Endocrinol Metab. 2023. PMID: 37988664 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources